Clinical Trials Directory

Trials / Completed

CompletedNCT06389903

Subthalamic Nucleus Stimulation Electrode and Psychiatric Lesion Effects in Parkinson's Disease

Study of Symptoms Related to the Lesion Effect Associated With the Implantation of Electrodes for Stimulation of the Subthalamic Nuclei in the Treatment of Parkinson's Disease.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Centre Hospitalier du Rouvray · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a pilot, prospective, monocentric study concerning 15 Parkinson's disease patients requiring deep brain stimulation implantation. The primary objective is to evaluate the psychiatric lesion effects of deep brain stimulation in patients with Parkinson's disease, using the Young Mania Rating Scale (YMRS), Big Five Inventory and the Hamilton Depression Rating Scale (HAMD 21).

Detailed description

The patients included were adults suffering from Parkinson's disease (according to ICD-10). They had no severe psychiatric disorders, and no major neurocognitive disorders contraindicating surgery. An initial evaluation will be carried out 72 hours after surgery, then after one month, and finally 3 months after surgery.

Conditions

Interventions

TypeNameDescription
BEHAVIORALassessmentpost-surgery behavioral assessment using scales

Timeline

Start date
2019-06-04
Primary completion
2020-07-03
Completion
2021-10-05
First posted
2024-04-29
Last updated
2024-04-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06389903. Inclusion in this directory is not an endorsement.

Subthalamic Nucleus Stimulation Electrode and Psychiatric Lesion Effects in Parkinson's Disease (NCT06389903) · Clinical Trials Directory